Skip to main content
logo
ADARx Pharmaceuticals, Inc. (ADRX)
ADARx Pharmaceuticals will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

ADARx Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending
TTMDec '25 Dec '24
Cash & Equivalents
58.4866.5214.03
Short-Term Investments
368.77413.48205.44
Cash & Cash Equivalents
427.25480219.48
Cash Growth
-118.70%-
Other Current Assets
14.2913.386.19
Total Current Assets
441.54493.38225.67
Property, Plant & Equipment
-4.732.97
Goodwill and Intangibles
-7.344.16
Other Long-Term Assets
-2.210.66
Total Long-Term Assets
-14.287.79
Total Assets
-507.66233.45

Liabilities

Year Ending
TTMDec '25 Dec '24
Accounts Payable
-5.841.35
Deferred Revenue
-16.56-
Current Debt
-1.710.79
Other Current Liabilities
34.016.376.8
Total Current Liabilities
34.0130.498.94
Long-Term Debt
-6.033.54
Other Long-Term Liabilities
-315.780.51
Total Long-Term Liabilities
-321.84.04
Total Liabilities
-352.2912.98

Shareholders' Equity

Year Ending
TTMDec '25 Dec '24
Retained Earnings
--220.7-147.61
Comprehensive Income
-1.960.34
Shareholders' Equity
-251.05-202.26-137.15

Additional Metrics

Year Ending
TTMDec '25 Dec '24
Total Debt
6.97.744.33
Debt Growth
-78.82%-
Net Cash (Debt)
420.35472.26215.15
Net Cash (Debt) Growth
-119.50%-
Working Capital
407.53462.89216.73